Evidence map›Paper›PMID 26634153›Full record

ReviewCholesterol2015

Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics.

Juan Salazar, Luis Carlos Olivar, Eduardo Ramos, Mervin Chávez-Castillo, Joselyn Rojas, Valmore Bermúdez

Open access · hybridAbstract readReview
In one paragraph

Review in Cholesterol, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Effect of Clinical and Laboratory Parameters on HDL Particle Composition.International journal of molecular sciences · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Juan SalazarEndocrine-Metabolic Research Center, "Dr. Félix Gómez," Faculty of Medicine, University of Zulia, Zulia State, Maracaibo 4004, Venezuela.
Luis Carlos OlivarEndocrine-Metabolic Research Center, "Dr. Félix Gómez," Faculty of Medicine, University of Zulia, Zulia State, Maracaibo 4004, Venezuela.
Eduardo RamosEndocrine-Metabolic Research Center, "Dr. Félix Gómez," Faculty of Medicine, University of Zulia, Zulia State, Maracaibo 4004, Venezuela.
Mervin Chávez-CastilloEndocrine-Metabolic Research Center, "Dr. Félix Gómez," Faculty of Medicine, University of Zulia, Zulia State, Maracaibo 4004, Venezuela.
Joselyn RojasEndocrine-Metabolic Research Center, "Dr. Félix Gómez," Faculty of Medicine, University of Zulia, Zulia State, Maracaibo 4004, Venezuela.
Valmore BermúdezEndocrine-Metabolic Research Center, "Dr. Félix Gómez," Faculty of Medicine, University of Zulia, Zulia State, Maracaibo 4004, Venezuela.
Universidad del Zulia · VE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-Density Lipoprotein-Cholesterol (HDL-C) is regarded as an important protective factor against cardiovascular disease, with abundant evidence of an inverse relationship between its serum levels and risk of cardiovascular disease, as well as various antiatherogenic, antioxidant, and anti-inflammatory properties. Nevertheless, observations of hereditary syndromes featuring scant HDL-C concentration in absence of premature atherosclerotic disease suggest HDL-C levels may not be the best predictor of cardiovascular disease. Indeed, the beneficial effects of HDL may not depend solely on their concentration, but also on their quality. Distinct subfractions of this lipoprotein appear to be constituted by specific protein-lipid conglomerates necessary for different physiologic and pathophysiologic functions. However, in a chronic inflammatory microenvironment, diverse components of the HDL proteome and lipid core suffer alterations, which propel a shift towards a dysfunctional state, where HDL-C becomes proatherogenic, prooxidant, and proinflammatory. This heterogeneity highlights the need for further specialized molecular studies in this aspect, in order to achieve a better understanding of this dysfunctional state; with an emphasis on the potential role for proteomics and lipidomics as valuable methods in the search of novel therapeutic approaches for cardiovascular disease.

Identifiers

PMID26634153
PMCPMC4655037
OpenAlexW2181217557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.